Skip to main content

Table 2 The associations of the quartile of serum carotenoids, relative to Quartile 1 with VAI

From: Associations of serum carotenoids with visceral adiposity index and lipid accumulation product: a cross-sectional study based on NHANES 2001–2006

Categories

Range

Model1

Model2

Model3

β (95%CI)

β (95%CI)

β (95%CI)

α-carotene (ug/dL)

    

Continuous

 

−0.29 (− 0.36, − 0.21)

−0.31 (− 0.39, − 0.23)

−0.25 (− 0.33, − 0.16)

Q1

< 1.40

ref

ref

ref

Q2

1.40–2.70

−0.47 (− 0.82, − 0.12)

−0.52 (− 0.88, − 0.16)

−0.49 (− 0.83, − 0.14)

Q3

2.70–5.00

−0.64 (− 0.95, − 0.33)

−0.73 (− 1.05, − 0.40)

−0.70 (− 1.04, − 0.36)

Q4

≥ 5.00

−0.93 (− 1.24, − 0.63)

−1.05 (− 1.38, − 0.72)

−0.98 (− 1.34, − 0.62)

P for trend

 

< 0.001

< 0.001

< 0.001

β-carotene (ug/dL)

    

Continuous

 

−0.35 (− 0.47, − 0.24)

−0.41 (− 0.54, − 0.27)

−0.32 (− 0.44, − 0.20)

Q1

< 7.50

ref

ref

ref

Q2

7.50–12.89

−0.59 (− 0.93, − 0.26)

−0.65 (− 0.99, − 0.30)

−0.62 (− 0.97, − 0.26)

Q3

12.89–23.30

−0.73 (− 1.01, − 0.46)

−0.86 (− 1.15, − 0.57)

−0.85 (− 1.17, − 0.54)

Q4

> 23.30

−1.28 (− 1.60, − 0.96)

−1.52 (− 1.87, − 1.17)

−1.39 (− 1.77, − 1.00)

P for trend

 

< 0.001

< 0.001

< 0.001

β-cryptoxanthin (ug/dL)

    

Continuous

 

−0.26 (− 0.38, − 0.14)

−0.27 (− 0.39, − 0.14)

−0.28 (− 0.42, − 0.14)

Q1

< 4.80

ref

ref

ref

Q2

4.80–7.70

−0.42 (− 0.77, − 0.08)

−0.41 (− 0.75, − 0.07)

−0.42 (− 0.76, − 0.09)

Q3

7.70–12.70

−0.60 (− 0.89, − 0.32)

−0.60 (− 0.88, − 0.32)

−0.57 (− 0.90, − 0.24)

Q4

> 12.70

−0.76 (− 1.08, − 0.43)

−0.78 (− 1.10, − 0.45)

−0.79 (− 1.18, − 0.41)

P for trend

 

< 0.001

< 0.001

< 0.001

Lutein/zeaxanthin (ug/dL)

    

Continuous

 

−0.18 (− 0.28, − 0.08)

−0.23 (− 0.32, − 0.13)

−0.28 (− 0.39, − 0.16)

Q1

< 10.46

ref

ref

ref

Q2

10.46–14.50

−0.09 (− 0.41, 0.22)

−0.12 (− 0.43, 0.19)

−0.19 (− 0.46, 0.09)

Q3

14.50–20.10

−0.42 (− 0.62, − 0.21)

−0.47 (− 0.68, − 0.27)

−0.54 (− 0.79, − 0.29)

Q4

≥ 20.10

−0.40 (− 0.64, − 0.16)

−0.51 (− 0.75, − 0.27)

−0.68 (− 0.96, − 0.39)

P for trend

 

< 0.001

< 0.001

< 0.001

Trans-lycopene (ug/dL)

    

Continuous

 

−0.12 (− 0.24, 0.00)

−0.08 (− 0.21, 0.04)

−0.33 (− 0.53, − 0.12)

Q1

< 14.00

ref

ref

ref

Q2

14.00–20.11

−0.48 (− 0.85, − 0.09)

−0.39 (− 0.78, 0.00)

−0.38 (− 0.81, 0.04)

Q3

20.11–28.23

−0.39 (− 0.79, 0.00)

−0.28 (− 0.70, 0.14)

−0.46 (− 0.96, 0.04)

Q4

≥ 28.23

−0.48 (− 0.87, − 0.10)

−0.38 (− 0.78, 0.02)

−0.88 (− 1.50, − 0.27)

P for trend

 

0.023

0.104

0.005

  1. Model 1: no cofounder; Model 2: adjusted for age, sex; Model 3: further adjusted for race, education level, marital status, alcohol intake, smoking status, leisure-time physical activity, BMI, the family of poverty ratio, TC, hypertension, diabetes, and CVD.